Search for:
Category

Singapore

Category
In Product Regulation & Liability

Singapore: HSA launches voluntary notification initiative for health supplements and traditional medicines

by 4 Mins Read

To facilitate better traceability and follow-up actions in the event of safety or quality issues, the Health Science Authority (HSA) is launching a voluntary notification initiative for health supplements and traditional medicines. From 1 August 2022, companies may submit documents regarding their products to the HSA. If the products meet the necessary safety and quality standards and labelling requirements, they will be published on the HSA’s database, which patients and consumers can refer to when considering suitable health supplements and traditional medicines.

Read More
In

Singapore: PDPC publishes guide on responsible use of biometric data in security applications

by , , and 7 Mins Read

In May 2022, the Singapore Personal Data Protection Commission published a guide to help organisations collect, use or disclose individuals’ biometric data in a responsible manner. With security applications like security cameras and Closed-Circuit Television Cameras becoming increasingly commonplace, there have been more cases of organisations mishandling individuals’ biometric data. The release of this guide serves as a timely reminder for organisations to review their existing measures or implement new measures to ensure that they are dealing with individuals’ biometric data in a responsible manner.

Read More
In Product Regulation & Liability

Singapore: Updates to the HSA’s Software as a Medical Device regulatory framework

by 7 Mins Read

In April 2022, the Health Sciences Authority published its revised Regulatory Guidelines for Software Medical Devices. It has also finalised its new Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Software, which had been released for public consultation in July to August 2021.

In Asia-Pacific

Singapore: MOH’s recent initiatives to raise awareness of the risks of direct-to-consumer genetic testing

by and 7 Mins Read

Given the increasing popularity of direct-to-consumer genetic testing, the Ministry of Health has taken various initiatives to raise awareness of the risks arising from the use of such tests. In addition to various social media advertisements since December 2021 and issuing an advisory for consumers in August 2021, the MOH also issued a guidance document for providers of non-clinical genetic testing in May 2021.

Read More
Load More